Biotech Trading Tools

5 essential calculators and export tools for PDUFA event-driven trading

Free access • Built for precision • Real-world validated

Tools Suite

ToolWhat It DoesFreePro
IV Crush CalculatorSimulate IV impact post-PDUFA decision. Input current IV rank, expected drop %, option Greeks.
Options P/L EstimatorCalculate profit/loss for long calls, puts, spreads across different price & IV scenarios.
Catalyst Timeline BuilderVisualize key dates: trial readout, PDUFA announcement, runup period (T-25 to T-7), decision date.
.ICS Export (Calendar)Export upcoming PDUFA dates to Google Calendar, Outlook, Apple Calendar. Auto-syncs updates.-
CSV Export (Data)Export filtered catalyst data, ODIN tiers, historical outcomes to CSV. Use in Excel or Python analysis.-

Free tier includes core calculators (IV Crush, Options P/L, Timeline Builder). Pro tier adds calendar sync and data export.

Understanding IV Crush

IV crush is the single largest risk factor for biotech options traders. When a PDUFA decision is announced (approval or rejection), implied volatility drops sharply (typically 40-60%), crushing the value of both calls and puts—regardless of which way the stock moved.

Historical IV Crush Data

  • Nano-cap PDUFAs: Avg 55% IV drop on decision day
  • Micro-cap PDUFAs: Avg 48% IV drop
  • Small-cap PDUFAs: Avg 38% IV drop
  • IV typically recovers 60-70% within 5 days post-event

Example: A "Wrong Way" Win

You buy a nano-cap call for $0.80. Stock rallies +15% on approval. But IV drops 55%, which wipes out 60% of your theoretical profit. Your call is now worth only $1.20 (instead of $2.00). That's the IV crush effect—the stock was right, but the option lost money anyway.

Our IV Crush Calculator helps you model this risk BEFORE you enter. Input your entry price, expected IV drop, and stock move—the tool shows your actual breakeven and max profit/loss.

Common Workflows

Workflow 1: Pre-Trade Options Analysis

  1. 1. Find a TIER_1 or TIER_2 PDUFA candidate on the heatmap
  2. 2. Open the Options P/L Estimator
  3. 3. Enter: current call price, strike, stock price, IV rank
  4. 4. Model scenarios: stock +5%, stock +10%, IV drops 50%
  5. 5. Identify breakeven stock move (accounting for IV crush)
  6. 6. Only enter if breakeven < 3% move (high probability runup)

Workflow 2: Calendar Syncing (Pro)

  1. 1. Filter heatmap by your watchlist (TIER_1/2 only)
  2. 2. Click "Export to Calendar" (ICS format)
  3. 3. Import to Google Calendar / Outlook / Apple Calendar
  4. 4. Catalysts auto-sync daily. You'll never miss a runup window.

Workflow 3: Backtesting with CSV Export (Pro)

  1. 1. Filter heatmap by date range (e.g., all 2024 PDUFA dates)
  2. 2. Click "Export CSV" (includes ODIN tiers, outcomes)
  3. 3. Load into Excel or Python (pandas, numpy)
  4. 4. Run backtest: how many T-25-T-7 runups were profitable by ODIN tier?

Frequently Asked Questions

Does the IV Crush Calculator account for dividend risk?

The calculator focuses on volatility and stock price impact. Biotech stocks rarely pay dividends, so this isn't typically a factor. However, if your underlying does pay (rare), manually adjust stock price down by dividend amount before running the scenario.

Can I use the Timeline Builder for earnings calls?

Yes. While designed for PDUFA events, the Timeline Builder works for any binary catalyst: earnings, phase readout, FDA meeting, analyst day, etc. It's flexible enough to model any multi-stage event timeline.

How often does the CSV export update?

CSV exports are generated on-demand. When you click "Export CSV", you get a snapshot of the current data (including latest ODIN tiers and outcomes). If you want daily updates, set a reminder to re-export weekly. Pro users have the option to schedule auto-exports (coming soon).

PDUFA Calendar 2026What Is a PDUFA Date?ODIN EnginePricing & PlansQ1 Oncology PDUFAsGlossary

Important: PDUFA.BIO is not the FDA. ODIN scores are ML model outputs, not financial advice. All investing carries risk. Read full disclaimer →

PDUFA.BIO
Tue Mar 3, 2026
12 this week

Biotech Trading Tools

Free tools for event-driven biotech trading: IV crush calculator, options profit/loss estimator, and position sizing for FDA PDUFA binary events.

Trading Toolkit

Institutional-grade analysis tools for biotech catalysts

Simulates how options pricing changes when Implied Volatility (IV) collapses after a binary catalyst event. Biotech PDUFAs routinely see IV crush of 40-60%. Even if the stock rises, your call may lose value.
IV CRUSH SIMULATOR
Stock Price
Strike
Pre-Event IV
Post-Event IV
Days to Expiry
Stock Move
PRE-EVENT
$6.73
POST-EVENT
$3.81
P&L
-43.4%
IV Trap Detected: Stock rises 10% but your call LOSES 43.4% due to IV crush from 150% → 60%.
TYPICAL IV CRUSH BY EVENT TYPE
PDUFA (Binary)
-40-60%Extreme
Phase 3 Readout
-30-50%Very High
Phase 2 Readout
-20-40%High
Conference Presentation
-10-20%Moderate

PDUFA.BIO

FDA catalyst intelligence powered by the ODIN v1108 scoring engine. Trained on 2,200+ PDUFA decisions & 2,000+ phase readouts (2015–2026).

PLATFORM

LEARN

PDUFA.BIO is the data-driven FDA PDUFA calendar and biotech catalyst calendar built for quantitative investors. Track upcoming PDUFA dates for 2026, FDA drug approval action dates, and biotech earnings dates in a unified, filterable calendar. Learn what a PDUFA date is and how the ODIN AI scoring engine generates FDA approval probability scores. Use the biotech catalyst screener to filter by ticker, therapeutic area, and ODIN tier. Explore the PDUFA runup strategy and verify ODIN's accuracy on the verified track record page. Browse our biotech glossary and catalyst research hub.

DISCLAIMER: PDUFA.BIO is not affiliated with, endorsed by, or connected to the U.S. Food & Drug Administration (FDA) or any government agency. The name "PDUFA" refers to the Prescription Drug User Fee Act and is used descriptively. This site does not provide financial, investment, legal, or medical advice. PDUFA.BIO is not a registered investment advisor, broker-dealer, or financial planner. Probability scores are generated by machine-learning models based on historical data and publicly available information. These scores are statistical estimates, not predictions or guarantees of FDA action or securities performance. Past approval rates do not guarantee future results.

RISK WARNING: Investing in biotechnology and pharmaceutical securities involves substantial risk, including the risk of total loss of capital. Binary catalyst events (such as PDUFA dates) can result in extreme price volatility. You should not invest money you cannot afford to lose. Always consult with a qualified financial advisor before making investment decisions. PDUFA.BIO, its operators, contributors, and affiliates accept no responsibility or liability for any losses arising from use of this site.

© 2026 PDUFA.BIO — All rights reserved.Market data via FMP · Social data via LunarCrush